Course Information
UCLA Heart Failure Symposium 2017

Marina del Rey Marriott
Marina del Rey, California
May 06, 2017

Download: [ PDF ]

Course Description

The heart failure syndrome, which affects approximately 6 million Americans, is the most common diagnosis for acute hospitalization in patients over 65 years. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. A continuum-of-care concept will benefit the individual patient, the heart failure population and healthcare economics. UCLA Health wants to enhance the role of the primary care physician/cardiologist as the central provider of continuity of care for our heart failure patients.

Advances in mechanical circulatory support (MCS) over the past two decades have revolutionized the field of advanced heart failure management especially with the advent of left ventricular assist devices (LVAD) that are FDA approved for lifelong use in patients who are not heart transplant candidates. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from MCS therapy. UCLA has been at the forefront in Heart Transplantation and Mechanical Circulatory Support. With more and more patients needing and living with LVADs in Southern California, there is a significant need to partner with the community for shared care and management of these patients in the long term. 

The Sixth Annual UCLA Heart Failure Symposium 2017 will: (1) discuss general heart failure treatment options focusing on lifetime mechanical circulatory support, (2) promote general understanding of MCS therapy and management of patients with lifelong LVADs, and (3) emphasize the need for developing networks linking academic centers with community physicians to manage these patients through the evolution of their disease pre- and post-LVAD therapy. 

Target Audience

Family practitioners, internists, cardiologists, pediatricians, nurses and all other healthcare professionals taking care of heart failure patients, as well as the interested lay public. 

Registration Information

Enrollment

Enrollment in this seminar is limited, so we suggest you enroll early.

Online

To enroll click here

By Mail

Send the completed enrollment form to:

David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
UCLA Heart Failure Symposium 2017
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512


By FAX

Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.

By Phone

Use your MasterCard, VISA, American Express or Discover card. Call (310) 794-2620.

Registration Fee

  • $35.00

Faculty

Course Chairs

Eugene C. DePasquale, MD
Assistant Clinical Professor of Medicine
Associate Director, Outpatient
Heart Transplantation
Advanced Heart Failure, Heart Transplantation and Mechanical Circulatory Support Program

Ali Nsair, MD
Assistant Professor of Medicine
Associate Medical Director of Mechanical
Circulatory Support Services
Heart Failure, Heart Transplantation,
Broad Stem Cell Research Center

UCLA Course Faculty and Panel Participants

Abbas Ardehali, MD
Professor of Surgery & Medicine
William E Conner Chair in Cardiothoracic Transplantation
Director, UCLA Heart & Lung Transplantation Program

Arnold S. Baas, MD, FACC, FACP
Associate Professor of Medicine
Cardiomyopathy, Heart Transplant and Mechanical 
Circulatory Support, UCLA Division of Cardiology

Martin Cadeiras, MD
Assistant Clinical Professor 
Division of Cardiovascular Disease

Amy Chang, RN, BSN, CCRN
Mechanical Circulatory Support
Coordinator at UCLA Health
Ronald Reagan UCLA Medical Center

Julie Creaser, RN, MN
Advanced Practice Nurse
Ronald Reagan UCLA Medical Center

Daniel Cruz, MD, PhD
Assistant Clinical Professor
Division of Cardiovascular Disease

Ravi Dave, MD
Associate Clinical Professor of Medicine
Division of Cardiology

Mario Deng, MD, FACC, FESC 
Professor of Medicine and Medical Director
Integrated Advanced Heart Failure / Mechanical Circulatory Support / Heart Transplantation Program

Lily Honoris, MD
Advanced Heart Failure Fellow

Tamara Horwich, MD
Associate Clinical Professor of Medicine
Medical Director, UCLA Cardiac
Rehabilitation Program
Co-Director, UCLA Women’s Cardiovascular
Health Center

Cathy Levenstein, LCSW
Clinical Social Worker
UCLA Mechanical Circulatory Support / Heart
Transplantation Program

Elan Moreno, RN, BSN, CCRN
Mechanical Circulatory Support
Coordinator at UCLA Health
Ronald Reagan UCLA Medical Center

Leigh Reardon, MD
Assistant Clinical Professor of Medicine
Director, Transitional Cardiac Care
Director, Pediatric Mechanical Circulatory Support

Darlene Rourke, RN, MSN, CHFN
Advanced Practice Nurse
Ahmanson-UCLA Cardiomyopathy Center

Anthony Salimbangon, RN, BSN, CCRN
Mechanical Circulatory Support Coordinator at UCLA Health
Ronald Reagan UCLA Medical Center

Kalyanam Shivkumar, MD, PhD
Professor of Medicine, Radiology & Bioengineering
Director, UCLA Cardiac Arrhythmia Center & EP Programs
Director & Chief, Interventional CV Programs & Cardiac Catheterization Laboratories

William Suh, MD
Assistant Clinical Professor of Medicine

Darko Vucicevic, MD
Advanced Heart Failure Fellow

Program Agenda

Saturday, May 6, 2017

7:45 Welcome and Introduction
Advanced Heart Failure Therapies: State-of-the-Art
Moderators: Arnold S. Baas, MD, FACC, FACP and Mario Deng, MD, FACC, FESC
8:00 The Evolving Landscape in the Medical Treatment of Heart Failure
Tamara Horwich, MD
8:20 Update on Device Therapy in Heart Failure: ICD, CRT and Ablation
Kalyanam Shivkumar, MD, PhD
8:40 Surgical Considerations for Advanced Heart Failure (High Risk CABG/Valve, OHT & MCS)
Abbas Ardehali, MD
9:00 TAVR in Heart Failure Patients with Severe Aortic Stenosis
William Suh, MD
9:20 To Clip or Not to Clip? - The Challenge of Mitral Regurgitation
Ravi Dave, MD
9:40 When CABG, VAD, or Transplant Is Not An Option. Complex High Risk Revascularization and Percutaneous Support
Ali Nsair, MD
10:00 Break
Care for the Heart Failure Patient
Moderators: Martin Cadeiras, MD and Julie Creaser, RN, MN
10:20 Patient Selection for Advanced Therapies
Arnold S. Baas, MD, FACC, FACP
10:40 A Shocking Situation: Emergent Therapies for Cardiogenic Shock
Daniel Cruz, MD, PhD
11:00 Care of the Heart Transplant Recipient in 2017
Eugene C. DePasquale, MD
11:20 Care of the VAD Recipient in 2017
Martin Cadeiras, MD
11:40 Care and Interventions in the Congenital Cardiac Patient Population
Leigh Reardon, MD
12:15 Lunch
Putting It Together
Moderators: Ali Nsair, MD and Eugene C. DePasquale, MD
1:30 The Patient Perspective
Mario Deng, MD, FACC, FESC
Panel Discussion - Lead:
Cathy Levenstein, LCSW and Mario Deng, MD, FACC, FESC
2:00 - 2:45 BREAKOUT 1
Remote Monitoring to Optimize Heart Failure Care - When is Hemodynamic Monitoring Indicated: Challenging Clinical Cases
Darlene Rourke, RN, MSN, CHFN and Julie Creaser, RN, MN

Moderator: Ali Nsair, MD and Martin Cadeiras, MD
  • NPs present overview of remote hemodynamic monitoring and other tools to optimize heart failure patients and present cases for discussion with breakout group

BREAKOUT 2
Tools of the Trade: Hands-on Experience with New Advanced Heart Failure Technologies (durable LVADS, temporary LVAD support, total artificial heart, and remote hemodynamic monitoring)
Elan Moreno, RN, BSN, CCRN, Anthony Salimbangon, RN, BSN, CCRN, Amy Chang, RN, BSN, CCRN
3:30 - 4:15 Clinical Conundrums: What Would You Do? – Continued Medical Therapy, VAD, or Transplant?
Case Presenters: Darko Vucicevic, MD and Lily Honoris, MD
Moderator: Daniel Cruz, MD, PhD and Mario Deng, MD, FACC, FESC
Expert Discussants: CV, CTS, NP/VAD Coordinator
  • Complex heart failure cases are discussed for therapeutic options
  • Frailty in the geriatric patient and DT VAD
  • When is high risk too prohibitive for surgical interventions: CABG, Valve, VAD or Transplant?
4:15 Reception for Attendees/Faculty & Adjourn

Objectives

At the conclusion of the program participants will be able to:

  • Identify the epidemiology and pathophysiology of heart failure and the need for mechanical circulatory support with a growing heart failure population
  • Understand indications for and management of lifelong left ventricular assist device therapy
  • Implement shared care programs with the community to co-manage these complex patients pre- and post-LVAD therapy
  • Discuss the continuity aspect of care from the patient/caregiver perspective from pediatric to adult care and from primary to tertiary care

Accreditation

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.

Miscellaneous

Location

Marina del Rey Marriott
4100 Admiralty Way
Marina Del Rey, CA 90292
(310) 301-3000

Parking

Valet parking $14.00